Autosomal recessive polycystic kidney disease and congenital hepatic fibrosis: summary statement of a first National Institutes of Health/Office of Rare Diseases conference. J Pediatr 2006 Aug;149(2):159-64
Date
08/05/2006Pubmed ID
16887426Pubmed Central ID
PMC2918414DOI
10.1016/j.jpeds.2006.03.014Scopus ID
2-s2.0-33746655404 (requires institutional sign-in at Scopus site) 79 CitationsAbstract
Researchers and clinicians with expertise in autosomal recessive polycystic kidney disease and congenital hepatic fibrosis (ARPKD/CHF) and related fields met on May 5-6, 2005, on the National Institutes of Health (NIH) campus for a 1.5-day symposium sponsored by the NIH Office of Rare Diseases, the National Human Genome Research Institute (NHGRI), and in part by the ARPKD/CHF Alliance. The meeting addressed the present status and the future of ARPKD/CHF research.
Author List
Gunay-Aygun M, Avner ED, Bacallao RL, Choyke PL, Flynn JT, Germino GG, Guay-Woodford L, Harris P, Heller T, Ingelfinger J, Kaskel F, Kleta R, LaRusso NF, Mohan P, Pazour GJ, Shneider BL, Torres VE, Wilson P, Zak C, Zhou J, Gahl WAAuthor
Ellis D. Avner MD Professor in the Pediatrics department at Medical College of WisconsinMESH terms used to index this publication - Major topics in bold
Angiotensin-Converting Enzyme InhibitorsAnticholesteremic Agents
Bile Ducts
Calcium Channels
Child
Disease Progression
Gene Expression
Humans
Hypertension, Portal
Kidney Tubules, Distal
Kidney Tubules, Proximal
Liver Cirrhosis
Phenotype
Phosphoric Diester Hydrolases
Point Mutation
Polycystic Kidney, Autosomal Recessive
Receptors, Cell Surface
